Precursor Cell Lymphoblastic Leukemia-Lymphoma  >>  Decadron (dexamethasone)  >>  Phase N/A
Welcome,         Profile    Billing    Logout  

4 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Decadron (dexamethasone) / Merck (MSD)
AALL00P2, NCT00016302: Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia

Completed
N/A
100
US
prednisone, DeCortin, Deltra, vincristine sulfate, leurocristine sulfate, VCR, Vincasar PFS, daunorubicin hydrochloride, Cerubidin, Cerubidine, daunomycin hydrochloride, daunorubicin, RP-13057, asparaginase, ASNase, Colaspase, Crasnitin, Elspar, L-ASP, methotrexate, amethopterin, Folex, methylaminopterin, Mexate, MTX, cyclophosphamide, CPM, CTX, Cytoxan, Endoxan, Endoxana, cytarabine, ARA-C, arabinofuranosylcytosine, arabinosylcytosine, Cytosar-U, cytosine arabinoside, mercaptopurine, 6-mercaptopurine, 6-MP, Leukerin, MP, leucovorin calcium, CF, CFR, LV, dexamethasone, Aeroseb-Dex, Decaderm, Decadron, DM, DXM, doxorubicin hydrochloride, ADM, ADR, Adria, Adriamycin PFS, Adriamycin RDF, thioguanine, 6-TG, radiation therapy, irradiation, radiotherapy, therapy, radiation, nelarabine, 506U78, Arranon, GW506U78, pegaspargase, L-asparaginase with polyethylene glycol, Oncaspar, PEG-ASP, PEG-L-asparaginase, pharmacological study, pharmacological studies, laboratory biomarker analysis
National Cancer Institute (NCI)
T-cell Childhood Acute Lymphoblastic Leukemia, Untreated Childhood Acute Lymphoblastic Leukemia
07/07
 
NCT00248547: Aprepitant in Preventing Nausea and Vomiting in Patients Who Are Undergoing a Stem Cell Transplant

Completed
N/A
40
US
aprepitant, Emend, dexamethasone, Decadron, ondansetron, Zofran, placebo, placebo, sugar pill
OHSU Knight Cancer Institute
Cancer
01/09
01/09
NCT00293384: Aprepitant, Granisetron, & Dexamethasone in Preventing Nausea & Vomiting in Pts. Receiving Cyclophosphamide Before a Stem Cell Transplant

Completed
N/A
40
US
Aprepitant, Emend, Cyclophosphamide, Cytoxan®, Neosar®, Dexamethasone, Decadron, Diodex, Hexadrol, Maxidex, Dexamethasone Sodium Phosphate, Dexamethasone Acetate, Granisetron hydrochloride, KYTRIL®
Barbara Ann Karmanos Cancer Institute, National Cancer Institute (NCI)
Breast Cancer, Chronic Myeloproliferative Disorders, Gestational Trophoblastic Tumor, Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms, Nausea and Vomiting, Neuroblastoma, Ovarian Cancer, Testicular Germ Cell Tumor
06/09
02/12
AALL02P2, NCT00096135: Combination Chemotherapy and Radiation Therapy in Treating Patients With Acute Lymphoblastic Leukemia That Has Relapsed in the CNS or Testes

Completed
N/A
168
US, Canada, Europe, RoW
filgrastim, Granulocyte Colony-Stimulating Factor, r-metHuG-CSF, G-CSF, Neupogen, NSC 614629, cyclophosphamide, CYTOXAN, NSC #26271, cytarabine, Cytosine arabinoside, Ara-C, Cytosar, NSC #6387, daunorubicin hydrochloride, Daunomycin, rubidomycin, Cerubidine, NSC #82151, dexamethasone, Decadron, Hexadrol, Dexone, Dexameth, NSC #34521, etoposide, VePesid, Etopophos, VP-16, NSC #141540, leucovorin calcium, LCV, Wellcovorin, citrovorum factor, folinic acid, NSC 03590, mercaptopurine, 6-MP, Purinethol, 6-mercaptopurine, NSC #000755, methotrexate, MTX, amethopterin, Trexall, NSC #000740, pegaspargase, PEG-asparaginase, PEGLA, PEG-L-asparaginase, polyethylene glycol-L-asparaginase, Oncaspar, NSC 624239, therapeutic hydrocortisone, vincristine sulfate, Oncovin, VCR, LCR, NSC #67574, radiation therapy
Children's Oncology Group, National Cancer Institute (NCI)
Leukemia
09/13
 

Download Options